Q4 2018 BioCryst Pharmaceuticals Inc Earnings Call Transcript
Good morning, ladies and gentlemen, and welcome to the BioCryst Fourth Quarter 2018 Earnings Conference Call. (Operator Instructions) As a reminder, this conference call is being recorded for replay purposes.
It is now my pleasure to hand the conference over to John Bluth. Sir, you may begin.
Thanks, Brian. Good morning, and welcome to BioCryst's Fourth Quarter and Full Year 2018 Corporate Update and Financial Results Conference Call. Today's press release and accompanying slides are available on our website.
Participating on the call with me today are: CEO, Jon Stonehouse; CFO, Tom Staab; Chief Medical Officer, Dr. Bill Sheridan; and Chief Commercial Officer, Lynne Powell. Following their remarks, we will answer your questions.
Before we begin, I want to direct your attention to Slide 2, which discusses our use of forward-looking statements and potential risk factors regarding an investment in BioCryst. As detailed on the slide, today's conference call will contain forward-looking statements, including those statements
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |